Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01445613 · ClinicalTrials.gov registry record · NA
Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 1,203
- Enrollment target
NCT01445613 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,203 participants.
The verdict
NCT01445613, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,203 participants
- Enrollment target
Study Summary
The objective of the CANOPY trial is to assess the continued safety and effectiveness of the RX Acculink Carotid Stent System under commercial use in subjects at standard risk for adverse events from Carotid Endarterectomy (CEA) enrolled by physicians with a range of carotid stenting experience.
Interventions
- DEVICE RX Acculink Carotid Stent System (RX Acculink)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,203 participants |
| Start Date | 2011-10 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01445613
The ClinicalTrials.gov registry entry for NCT01445613 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RX Acculink Carotid Stent System (RX Acculink) is the first listed.
NCT01445613 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01445613 about?
NCT01445613 is a clinical study titled "Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy". The objective of the CANOPY trial is to assess the continued safety and effectiveness of the RX Acculink Carotid Stent System under commercial use in subjects at standard risk for adverse events from Carotid Endarterectomy (CEA) enrolled by physicians with a range of carotid stenting experience.
What is the current status of trial NCT01445613?
This trial is currently completed. It is a NA study. The enrollment target is 1,203 participants. The study started on 2011-10. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01445613?
The interventions under investigation include: RX Acculink Carotid Stent System (RX Acculink) (DEVICE).
Who is sponsoring clinical trial NCT01445613?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.